Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)
CNY 26.3
(0.88%)
CNY 26.3
(0.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 604.06 Million | 341.85 Million | 597.17 Million | 282.98 Million | 491.58 Million | 308.24 Million |
| Net Income | 451.83 Million | 480.3 Million | 474.05 Million | 430.64 Million | 353.39 Million | 164.55 Million |
| Depreciation & Amortization | 90.08 Million | 78.51 Million | 68.56 Million | 35.25 Million | 36.15 Million | 36.34 Million |
| Deferred income taxes | 2.13 Million | -6.59 Million | -1.02 Million | 7.29 Million | 2.56 Million | -23.89 Million |
| Stock-based compensation | -1.12 Million | -770 Thousand | -320 Thousand | 400 Thousand | 3.21 Million | - |
| Change in working capital | 127.89 Million | -251.18 Million | 78.94 Million | -116.3 Million | 98.27 Million | -43.76 Million |
| Other non-cash items | -167.83 Million | 41.59 Million | -23.05 Million | -74.29 Million | -2.01 Million | 151.1 Million |
| Investing Cash Flow | 448.27 Million | -618.76 Million | -63.04 Million | 269.9 Million | -13.71 Million | -64.16 Million |
| Investments in PPE | -248.36 Million | -75.01 Million | -65.09 Million | -45.4 Million | -46.35 Million | -24.96 Million |
| Acquisitions | -35.88 Million | 979.33 Thousand | 3.99 Million | -12.89 Million | 49.65 Million | - |
| Investment purchases | -2.03 Billion | -3.62 Billion | -3.41 Billion | -2.98 Billion | -2.26 Billion | -4.14 Billion |
| Sales/Maturities of investments | 2.7 Billion | 3.07 Billion | 3.4 Billion | 3.3 Billion | 2.29 Billion | 4.1 Billion |
| Other Investing Activities | 56.61 Million | -516.99 Thousand | 580.08 Thousand | 4.85 Million | -46.35 Million | 74.73 Thousand |
| Financing Cash Flow | -579.16 Million | 178.17 Million | -169.64 Million | -11.72 Million | -52.9 Million | -91.56 Million |
| Debt repayment | -391.11 Million | -88.21 Million | -123 Million | -50.14 Million | -31.55 Million | -9.45 Million |
| Dividends payments | -150.86 Million | -150.86 Million | -129.31 Million | -112.07 Million | -64.65 Million | -101.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -78.34 Million | 431.43 Million | 77.85 Million | 154.02 Million | 45.88 Million | 19.17 Million |
| Accounts receivables | 148.02 Million | -356.19 Million | 231.67 Million | -290.05 Million | 86.62 Million | -80.88 Million |
| Accounts payables | -75.44 Million | 137.86 Million | -105.32 Million | 151.65 Million | 62.66 Million | 90.04 Million |
| Inventory | 55.31 Million | -26.25 Million | -46.37 Million | 14.8 Million | -53.57 Million | -29.02 Million |
| Other working capital | -1.12 Million | -6.59 Million | -1.02 Million | 7.29 Million | 2.56 Million | -14.73 Million |
| Cash at beginning of period | 2.49 Billion | 2.4 Billion | 2.04 Billion | 1.5 Billion | 1.07 Billion | 924.27 Million |
| Cash at end of period | 2.98 Billion | 2.3 Billion | 2.4 Billion | 2.04 Billion | 1.5 Billion | 1.07 Billion |
| Capital Expenditure | -248.36 Million | -75.01 Million | -65.09 Million | -45.4 Million | -46.35 Million | -24.96 Million |
| Effect of forex changes on cash | 256.08 Thousand | 1.24 Million | -604.25 Thousand | -962.22 Thousand | -1.63 Million | 2.89 Million |
| Net cash flow / Change in cash | 494.51 Million | -97.48 Million | 363.87 Million | 540.2 Million | 423.33 Million | 155.4 Million |
| Free Cash Flow | 355.7 Million | 266.84 Million | 532.07 Million | 237.57 Million | 445.22 Million | 283.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 145.59 Million | 114.24 Million | 197.66 Million | 24.86 Million | 451.83 Million | 137.01 Million |
| Depreciation & Amortization | - | 21.9 Million | 21.9 Million | 22.21 Million | 90.08 Million | -37.21 Million |
| Deferred income taxes | - | - | - | -201.1 Million | 2.13 Million | -195.76 Million |
| Stock-based compensation | - | - | - | -1.12 Million | -1.12 Million | 560 Thousand |
| Change in working capital | - | -288.94 Million | - | 202.22 Million | 127.89 Million | 232.41 Million |
| Other non-cash items | -53.47 Million | 73.14 Million | -137.98 Million | 480.52 Million | -167.83 Million | -25.9 Million |
| Investing Cash Flow | -42.34 Million | -134.93 Million | -629.38 Million | 786.72 Million | 448.27 Million | 5.92 Million |
| Investments in PPE | -71.98 Million | -39 Million | -53.13 Million | -133.37 Million | -248.36 Million | -36.62 Million |
| Acquisitions | - | -50.00 | 50.00 | -63.46 Million | -35.88 Million | 3.04 Million |
| Investment purchases | -520.7 Million | -358.3 Million | -700.38 Million | 22.83 Million | -2.03 Billion | -408.73 Million |
| Sales/Maturities of investments | 550.34 Million | 262.36 Million | 124.13 Million | 910.31 Million | 2.7 Billion | 448.23 Million |
| Other Investing Activities | 2245.13 | -96.15 Million | -576.03 Million | 50.41 Million | 56.61 Million | -0.42 |
| Financing Cash Flow | -183.84 Million | -27.32 Million | -10.52 Million | -361.97 Million | -579.16 Million | -177.01 Million |
| Debt repayment | -3.1 Million | -10.97 Million | -890 Thousand | -300 Million | -391.11 Million | -33.01 Million |
| Dividends payments | -168.57 Million | -1.59 Million | -2.07 Million | -150.86 Million | -150.86 Million | -154.43 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.16 Million | -16.34 Million | -11.41 Million | -69.16 Million | -78.34 Million | 10.42 Million |
| Accounts receivables | - | -269.15 Million | - | 148.02 Million | 148.02 Million | 224.73 Million |
| Accounts payables | - | - | - | - | -75.44 Million | -560 Thousand |
| Inventory | - | -19.78 Million | - | 55.31 Million | 55.31 Million | 7.67 Million |
| Other working capital | - | - | - | -1.12 Million | -1.12 Million | 560 Thousand |
| Cash at beginning of period | 2.2 Billion | 2.41 Billion | 2.98 Billion | 1.83 Billion | 2.49 Billion | 1.89 Billion |
| Cash at end of period | 2.07 Billion | 2.44 Billion | 2.41 Billion | 2.78 Billion | 2.98 Billion | 1.83 Billion |
| Capital Expenditure | -71.98 Million | -39 Million | -53.13 Million | -133.37 Million | -248.36 Million | -36.62 Million |
| Effect of forex changes on cash | -3283.76 | 1848.43 | 99.51 | 290.34 Thousand | 256.08 Thousand | -42.91 Thousand |
| Net cash flow / Change in cash | -134.07 Million | 25.91 Million | -573.14 Million | 952.64 Million | 494.51 Million | -60.02 Million |
| Free Cash Flow | 20.13 Million | 126.48 Million | 6.53 Million | 394.22 Million | 355.7 Million | 74.48 Million |
001230
002023
603931
ESLA
CNNC
CBOX